@prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix rdf: . @prefix xsd: . @prefix dct: . @prefix dce: . @prefix pav: . @prefix np: . @prefix belv: . @prefix prov: . @prefix sdis: . @prefix go: . @prefix mesh: . @prefix occursIn: . @prefix species: . @prefix atcc: . @prefix pubmed: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:_1 occursIn: mesh:D001792, atcc:HTB-27.aspx, species:9606; rdf:object go:0008283; rdf:predicate belv:increases; rdf:subject sdis:tissue%20damage; a rdf:Statement . sub:assertion rdfs:label "path(SDIS:\"tissue damage\") -> bp(GO:\"cell proliferation\")" . } sub:provenance { beldoc: dce:description "Approximately 61,000 statements."; dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved."; dce:title "BEL Framework Large Corpus Document"; pav:authoredBy sub:_3; pav:version "1.4" . sub:_2 prov:value "breast carcinoma cell lines overexpressing (SKBR3, MDAMB453 and MDAMB361) and not overexpressing (MDAMB231, MDAMB435 and MCF7) HER2 receptor all 6 cell lines tested were induced to proliferate in response to the drainage fluids, although proliferation levels in the HER2-positive cell lines were consistently higher than in the HER2-negative ones"; prov:wasQuotedFrom pubmed:12932384 . sub:_3 rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource pubmed:12932384; prov:wasDerivedFrom beldoc:, sub:_2 . } sub:pubinfo { this: dct:created "2014-07-03T14:30:15.905+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }